Identification of a new serine protease from polychaeta, Marphysa sanguinea, for its thrombolytic and anticoagulant activity

被引:3
作者
Yeon, Seung Ju [1 ]
Shim, Kyou Hee [1 ]
Hong, Jae Sang [2 ,3 ]
Shin, Hwa Sung [1 ]
机构
[1] Inha Univ, Dept Biol Engn, Incheon 22212, South Korea
[2] Inha Univ, Dept Oceanog, Incheon 22212, South Korea
[3] Korea Inst Coastal Ecol Inc, Bucheon 14449, South Korea
基金
新加坡国家研究基金会;
关键词
Serine Protease; Marphysa sanguinea; Brain Ischemia; Thrombolysis; Anticoagulant; TISSUE-PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; FIBRINOLYTIC ENZYME; ISCHEMIC-STROKE; T-PA; PURIFICATION; UROKINASE; THERAPY; MECHANISM; EFFICACY;
D O I
10.1007/s11814-016-0331-z
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A serine protease was purified from Marphysa sanguinea through ammonium sulfate followed by ion exchange chromatography, and its N-terminal amino sequence was identified to be IVGGSEATPYQFPFQ. Fibrinolytic activity was depended on both direct fibrinolysis and indirect plasminogen-mediated cascade and had a consistent activity irrespective of pH. The serine protease could be confirmed to degrade alpha-, beta-, and gamma-chains of human fibrinogen through fibrinogenolytic assay and did not express significant cytotoxicity to endothelial cells. These imply the enzyme has anticoagulant as well as thrombolytic activity, not significantly impairing endothelial cells comprising brain blood brain barrier (BBB) tissue. Conclusively, the new serine protease is worthy of being a candidate to substitute tissue-Plasminogen Activator (t-PA) for acute ischemic reperfusion injury of brain.
引用
收藏
页码:781 / 786
页数:6
相关论文
共 38 条
  • [1] Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial
    Albers, Gregory W.
    von Kummer, Ruediger
    Truelsen, Thomas
    Jensen, Jens-Kristian S.
    Ravn, Gabriela M.
    Gronning, Bjorn A.
    Chabriat, Hugues
    Chang, Ku-Chou
    Davalos, Antonio E.
    Ford, Gary A.
    Grotta, James
    Kaste, Markku
    Schwamm, Lee H.
    Shuaib, Ashfaq
    [J]. LANCET NEUROLOGY, 2015, 14 (06) : 575 - 584
  • [2] Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator
    Alexandrov, AV
    Grotta, JC
    [J]. NEUROLOGY, 2002, 59 (06) : 862 - 867
  • [3] Equivocal roles of tissue-type plasminogen activator in stroke-induced injury
    Benchenane, K
    López-Atalaya, JP
    Fernández-Monreal, M
    Touzani, O
    Vivien, D
    [J]. TRENDS IN NEUROSCIENCES, 2004, 27 (03) : 155 - 160
  • [4] Camiolo S. M., 1971, EXP BIOL MED, V138, P227
  • [5] CAMIOLO SM, 1971, P SOC EXP BIOL MED, V138, P277
  • [6] Starase: A bi-functional fibrinolytic protease from hepatic caeca of Asterina pectinifera displays antithrombotic potential
    Choi, Jun-Hui
    Sapkota, Kumar
    Kim, Seung
    Kim, Sung-Jun
    [J]. BIOCHIMIE, 2014, 105 : 45 - 57
  • [7] Collen D, 1999, THROMB HAEMOSTASIS, V82, P259
  • [8] Purification and characterization of a novel fibrinolytic enzyme from the polychaete, Neanthes japonica (Iznka)
    Deng, Zhihui
    Wang, Shaohua
    Li, Qi
    Ji, Xue
    Zhang, Lianzhi
    Hong, Min
    [J]. BIORESOURCE TECHNOLOGY, 2010, 101 (06) : 1954 - 1960
  • [9] EISENBERG PR, 1987, THROMB HAEMOSTASIS, V57, P35
  • [10] ROLE OF FIBRINOGEN ALPHA-CHAIN AND GAMMA-CHAIN SITES IN PLATELET-AGGREGATION
    FARRELL, DH
    THIAGARAJAN, P
    CHUNG, DW
    DAVIE, EW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10729 - 10732